Gonadotropin-releasing hormone agonist with or without raloxifene: Effects on cognition, mood, and quality of life

Stefano Palomba, Francesco Orio, Tiziana Russo, Angela Falbo, Amato Amati, Fulvio Zullo

Research output: Contribution to journalArticle

Abstract

GnRH analogue (GnRH-a) administration induces a significant reduction of cognitive functions in premenopausal women with symptomatic uterine leiomyomas and, notwithstanding the appearance of climacteric-like symptoms, the effectiveness of analogue induces a significant improvement of mood and quality of life. The addition of raloxifene to GnRH-a treatment has no clinical effect on cognition, mood, and quality of life in this sample of women.

Original languageEnglish
Pages (from-to)480-482
Number of pages3
JournalFertility and Sterility
Volume82
Issue number2
DOIs
Publication statusPublished - Aug 2004

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Fingerprint Dive into the research topics of 'Gonadotropin-releasing hormone agonist with or without raloxifene: Effects on cognition, mood, and quality of life'. Together they form a unique fingerprint.

  • Cite this